
David Molyneux
VP, Business Development
Sterling Pharma Solutions
About me
With extensive small molecule API development and manufacturing capabilities in both the US and UK, I'm looking to connect with anybody who has a current or future requirement for small molecule API development and manufacturing services, including the development and clinical or commercial manufacture of: - HPAPIs - Hazardous chemistries - Advanced intermediates Please don't hesitate to get in touch to find out more, and I'll look forward to speaking with you soon!
Exhibitor Access Type
Exhibitor - In person
Country
United Kingdom
About me (Individual)
Job Function
Business Development Director
Contact details
Is member of

Sterling Pharma Solutions

Sterling Pharma Solutions
Exhibitors
Sterling Pharma Solutions
Exhibitors
Sterling Pharma Solutions
Exhibitors
Sterling Pharma Solutions
Exhibitorsis attending
Navigating Shifts in CDMO-Pharma Relations: Trends and Implications
Tuesday, October 8, 2024 9:35 AM to 10:30 AM
Hall 5 - 5B49
Gil Roth · Pharma & Biopharma Outsourcing Association
Faye Boeckman · Thermo Fisher Scientific
Fireside Chat – Navigating Outsourcing Partnerships for Start-Ups
Tuesday, October 8, 2024 11:15 AM to 11:40 AM
Hall 5 - 5B49
Kelly Howard · Thermo Fisher Scientific
Raman Sehgal · Molecule to Market
Optimizing ADC Processes: Advanced Strategies with High-Quality Bioreagents
Tuesday, October 8, 2024 11:45 AM to 12:10 PM
Hall 3 - 3F97
Dom Price · Thermo Fisher Scientific
Jean-Francois Vincent-Rocan · BIOVECTRA.
From the Rainforest to the Clinic. Turning a High-Potency Rare Natural Product Into an Anticancer API
Tuesday, October 8, 2024 1:15 PM to 1:40 PM
Hall 5 - 5B49
Federico Peterlongo · INDENA SPA
Why the Middle East can be the New Frontier for Next Generation Medicine
Tuesday, October 8, 2024 2:15 PM to 3:00 PM
Hall 22 - 22F50
Eleonora Brero · IQVIA
Eng. Abdullah Al-Ali · Ministry of Industry and Mineral Resources